Bank Of America Corp Invitae Corp Transaction History

Bank Of America Corp

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.42 - $0.72 $117,713 - $201,794	280,270 Added 70.36%	678,596 $427,000
Q2 2023 Aug 14, 2023	SELL	$1.05 - $1.63 $164,531 - $255,416	-156,697 Reduced 28.23%	398,326 $450,000
Q1 2023 May 12, 2023	BUY	$1.2 - $2.73 $30,112 - $68,506	25,094 Added 4.74%	555,023 $749,000
Q4 2022 Feb 10, 2023	BUY	$1.71 - $3.61 $159,105 - $335,888	93,044 Added 21.3%	529,929 $985,000
Q3 2022 Nov 14, 2022	SELL	$1.9 - $8.63 $330,164 - $1.5 Million	-173,771 Reduced 28.46%	436,885 $1.07 Million

Q2 2022 Aug 12, 2022	SELL	$2.13 - $9.01 $61,495 - $260,127	-28,871 Reduced 4.51%	610,656 $1.49 Million
Q1 2022 May 16, 2022	SELL	$6.28 - $15.59 $2.71 Million - $6.72 Million	-430,874 Reduced 40.25%	639,527 $5.1 Million
Q4 2021 Feb 08, 2022	SELL	$14.7 - $28.67 $4.32 Million - $8.42 Million	-293,825 Reduced 21.54%	1,070,401 $16.3 Million
Q3 2021 Nov 15, 2021	BUY	$24.31 - $33.6 $4.59 Million - $6.34 Million	188,747 Added 16.06%	1,364,226 $38.8 Million
Q2 2021 Sep 13, 2021	BUY	$26.09 - $40.4 $30.7 Million - $47.5 Million	1,175,479 New	1,175,479 $39.6 Million

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.